. Author manuscript; available in PMC: 2018 Sep 1.

Published in final edited form as: Depress Anxiety. 2017 Sep 29;34(12):1147–1156. doi: 10.1002/da.22681

Appendix Table 2.

Predicted Changes in Rates and Slopes in Incident Prescription Fills of Fluoxetine Before and After FDA Boxed Warning, by Race/Ethnicity (n=240)

	White	Black		Latino
	Estimate (SE)	Estimate (SE)	Different from White	Estimate (SE)	Different from White

Baseline Jan 2002 Rate^†	765.19 (79.87)	711.98(113.89)	ns	893.89(109.59)	ns

Change in rate after warning^Δ	658.57 (122.09)^***	763.31(182.28)^***	ns	840.25 (174.80)^***	ns

Slope (Δ/month) before warning^‡	10.56 (5.37)^*	10.37 (8.02)^*	ns	16.46 (7.69)^*	ns

Slope (Δ/month) after warning^‡	2.93 (0.86)^***	6.09(1.29)^***	^*	2.85 (1.24)^*	ns

Change in slope	−7.63 (5.45)	−4.28 (8.15)	ns	−13.60 (7.82)	ns

p<0.05,

^**

p<0.01,

^***

p<0.001

^†

Rate is number of incident fluoxetine prescription fills/10,000 youth per month

^‡

Slope is monthly change in number of prescription fills/10,000 youth

^Δ

Change in rate is level shift between October 2003 and October 2004